Mycosis fungoides primary prevention

Revision as of 20:37, 19 December 2018 by Sogand (talk | contribs)
Jump to navigation Jump to search

Cutaneous T cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Mycosis fungoides
Sezary syndrome

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

There are no established measures for the secondary prevention of mycosis fungoides but recommended effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease. every 4–6 weeks.

Secondary Prevention

effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease. every 4–6 weeks.[1]


References

  1. Willemze, R; Hodak, E; Zinzani, P L; Specht, L; Ladetto, M (2018). "Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†". Annals of Oncology. 29 (Supplement_4): iv30–iv40. doi:10.1093/annonc/mdy133. ISSN 0923-7534.

Template:WH Template:WS